Bailing Hou Selected Research

1- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amine

1/2019

Anxiety-induced hyperalgesia in female rats is mediated by cholecystokinin 2 receptor in rostral ventromedial medulla and spinal 5-hydroxytryptamine 2B receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bailing Hou Research Topics

Disease

10	Pain (Aches) 03/2022 - 09/2014
7	Bone Neoplasms (Bone Cancer) 12/2019 - 09/2014
5	Hyperalgesia 01/2019 - 01/2015
3	Neuralgia (Stump Neuralgia) 01/2021 - 01/2015
3	Inflammation (Inflammations) 08/2017 - 01/2015
2	Postoperative Pain 03/2022 - 01/2019
1	Chronic Pain 03/2022
1	Surgical Wound Infection 03/2022
1	Peripheral Nerve Injuries 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2017
1	Spinal Cord Compression 08/2017
1	Neoplasms (Cancer) 01/2016
1	Carcinoma (Carcinomatosis) 10/2015
1	Osteosarcoma (Osteogenic Sarcoma) 09/2014
1	Cancer Pain 09/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2014
3	Analgesics (Analgesic Drugs)IBA 03/2022 - 10/2015
3	CytokinesIBA 01/2017 - 01/2015
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 09/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2019 - 10/2015
2	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2019 - 01/2015
2	N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA 01/2019 - 01/2015
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2017 - 01/2015
2	JHW 015IBA 01/2017 - 10/2015
1	Hypnotics and Sedatives (Sedatives)IBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Transcription Factor Brn-3CIBA 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Cholecystokinin (Pancreozymin)IBA 01/2019
1	methyllycaconitineIBA 01/2019
1	Cholecystokinin B ReceptorIBA 01/2019
1	5-HT2B Serotonin ReceptorIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	YM 022IBA 01/2019
1	2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA 01/2019
1	1- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amineIBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Sincalide FDA Link 01/2019
1	Dexmedetomidine FDA Link 08/2017
1	Toll-Like Receptor 4IBA 08/2017
1	CB2 Cannabinoid ReceptorIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	CannabinoidsIBA 01/2017
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2017
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	bovine adrenal medulla 8-22IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	Interleukin-18 (Interleukin 18)IBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	OligodeoxyribonucleotidesIBA 03/2015
1	KinesinsIBA 03/2015
1	Opioid Analgesics (Opioids)IBA 01/2015
1	Remifentanil (Ultiva)FDA Link 01/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 09/2014
1	KN 93IBA 09/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2014

Therapy/Procedure

3	Spinal Injections 01/2019 - 10/2015
2	Therapeutics 03/2022 - 09/2014
1	Thoracotomy 03/2022
1	Analgesia 03/2022
1	Nerve Block (Nerve Blocks) 01/2021
1	Perioperative Period 01/2019
1	Injections 01/2019
1	Intraperitoneal Injections 01/2017